Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 11;10(2):e0117528.
doi: 10.1371/journal.pone.0117528. eCollection 2015.

The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer

Affiliations

The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer

Roland A Ammann et al. PLoS One. .

Abstract

Background: The temperature limit defining fever (TLDF) is based on scarce evidence. This study aimed to determine the rate of fever in neutropenia (FN) episodes additionally diagnosed by lower versus standard TLDF.

Methods: In a single center using a high TLDF (39.0°C tympanic temperature, LimitStandard), pediatric patients treated with chemotherapy for cancer were observed prospectively. Results of all temperature measurements and CBCs were recorded. The application of lower TLDFs (LimitLow; range, 37.5°C to 38.9°C) versus LimitStandard was simulated in silicon, resulting in three types of FN: simultaneous FN, diagnosed at both limits within 1 hour; earlier FN, diagnosed >1hour earlier at LimitLow; and additional FN, not diagnosed at LimitStandard.

Results: In 39 patients, 8896 temperature measurements and 1873 CBCs were recorded during 289 months of chemotherapy. Virtually applying LimitStandard resulted in 34 FN diagnoses. The predefined relevantly (≥15%) increased FN rate was reached at LimitLow 38.4°C, with total 44 FN, 23 simultaneous, 11 earlier, and 10 additional (Poisson rate ratioAdditional/Standard, 0.29; 95% lower confidence bound, 0.16). Virtually applying 37.5°C as LimitLow led to earlier FN diagnosis (median, 4.5 hours; 95% CI, 1.0 to 20.8), and to 53 additional FN diagnosed. In 51 (96%) of them, spontaneous defervescence without specific therapy was observed in reality.

Conclusion: Lower TLDFs led to many additional FN diagnoses, implying overtreatment because spontaneous defervescence was observed in the vast majority. Lower TLDFs led as well to relevantly earlier diagnosis in a minority of FN episodes. The question if the high TLDF is not only efficacious but as well safe remains open.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Types of FN diagnoses applying a low versus high TLDF.
Figure 2
Figure 2. Additional, earlier, and simultaneous FN diagnoses according to TLDF.
Figure 3
Figure 3. Cumulative proportion plots of TimeEarlier at different LimitLow in 34 FN episodes diagnosed at LimitStandard.
Figure 4
Figure 4. Ratio of additional/earlier FN diagnoses according to TLDF and definition of earlier FN diagnosis.
Time E/A, time limit differentiating earlier versus additional FN. Time E/S, time limit differentiating earlier versus simultaneous FN.

Similar articles

Cited by

References

    1. Koh AY, Pizzo PA (2011) Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG (eds): Principles and practice of pediatric oncology, 6th edn Philadelphia: Lippincott Williams & Wilkins; pp. 1190–1242.
    1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, et al. (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52: e56–93. 10.1093/cid/cir073 - DOI - PubMed
    1. Gibson F, Chisholm J, Blandford E, Donachie P, Hartley J, et al. (2013) Developing a national ‘low risk’ febrile neutropenia framework for use in children and young people’s cancer care. Support Care Cancer 21: 1241–1251. 10.1007/s00520-012-1653-y - DOI - PubMed
    1. Phillips B, Selwood K, Lane SM, Skinner R, Gibson F, et al. (2007) Variation in policies for the management of febrile neutropenia in United Kingdom Children’s Cancer Study Group centers. Arch Dis Child 92: 495–498. 10.1136/adc.2006.102699 - DOI - PMC - PubMed
    1. Ammann RA, Tissing WJ, Phillips B (2012) Rationalising the approach to children with fever in neutropenia. Curr Opin Infect Dis 25: 258–265. 10.1097/QCO.0b013e328351d199 - DOI - PubMed

Publication types

Substances